Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action

被引:0
|
作者
Dilani D. De Silva
Sylvie Rapior
Françoise Fons
Ali H. Bahkali
Kevin D. Hyde
机构
[1] Mae Fah Luang University,Institute of Excellence in Fungal Research
[2] Mae Fah Luang University,School of Science
[3] University of Peradeniya,Department of Botany, Faculty of Science
[4] University Montpellier 1,Faculty of Pharmacy
[5] UMR 5175 CEFE,Botany and Microbiology Department, College of Science
[6] King Saud University,undefined
来源
Fungal Diversity | 2012年 / 55卷
关键词
Medicinal mushrooms; Cancer; Anti-cancer; Immunomodulation; Bioactive metabolites;
D O I
暂无
中图分类号
学科分类号
摘要
Medicinal mushrooms have been valued as natural sources of bioactive compounds since times immemorial and have been recognized as potential immunomodulating and anti-cancer agents. Their consumption has consistently been shown to have beneficial effects on human health. Cancer is a generic term for several types of diseases that can be chronic and are responsible for a large number of deaths worldwide. Although there has been considerable progress in modern cancer therapy research, difficulties in understanding the molecular behavior of various types of cancers and the numerous side effects experienced by patients from treatments means that this whole subject area is still problematic. Thus, biological immunotherapy using natural bioactive compounds as supportive treatments in conventional cancer therapies has become in vogue. Bioactive metabolites isolated from medicinal mushrooms have shown potential successes in cancer treatment as biological immunotherapeutic agents that stimulate the immune system against cancer cells. They also act as an effective source of anti-cancer agents, capable of interfering with cellular signal transduction pathways linked to cancer development and progression. In this review we compile available data on the characteristics of medicinal mushrooms that appear to be particularly effective as biological immunotherapeutic agents. Major consideration is given to biological constituents and the putative mechanisms of action by which bioactive compounds act on the human body. Consideration is also given to the benefits that have been claimed for the use of mushrooms in treating cancer and the future prospects of using medicinal mushrooms as potent supportive candidate bioagents for treatment of cancers is discussed.
引用
收藏
页码:1 / 35
页数:34
相关论文
共 50 条
  • [41] Recent developments in mushrooms as anti-cancer therapeutics: a review
    Patel, Seema
    Goyal, Arun
    3 BIOTECH, 2012, 2 (01) : 1 - 15
  • [42] Recent developments in mushrooms as anti-cancer therapeutics: a review
    Seema Patel
    Arun Goyal
    3 Biotech, 2012, 2 : 1 - 15
  • [43] Critical Reviews on Anti-Cancer Effects of Edible and Medicinal Mushroom Phellinus linteus and Its Molecular Mechanisms
    Hu, Xinwen
    Ganesan, Kumar
    Khan, Haroon
    Xu, Baojun
    FOOD REVIEWS INTERNATIONAL, 2024, 40 (04) : 1118 - 1137
  • [44] Anti-Cancer and Medicinal Potentials of Moringa Isothiocyanate
    Wu, Yu-Yao
    Xu, Yan-Ming
    Lau, Andy T. Y.
    MOLECULES, 2021, 26 (24):
  • [45] Anti-cancer approach with NK4: Mechanisms and significance
    Matsumoto, Kunio
    Nakamura, Toshikazu
    JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 438 - 439
  • [46] Cancer stem cells: Toward novel anti-cancer therapies?
    Blomme, Eric A. G.
    VETERINARY JOURNAL, 2008, 177 (03): : 303 - 304
  • [47] Impact of the microbiome on cancer progression and response to anti-cancer therapies
    Rosean, Claire Buchta
    Feng, Tzu-Yu
    Azar, Francesca N.
    Rutkowski, Melanie R.
    IMMUNOTHERAPY OF CANCER, 2019, 143 : 255 - 294
  • [48] Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions
    Piretto, Elena
    Delitala, Marcello
    Kim, Peter S.
    Frascoli, Federico
    MATHEMATICAL BIOSCIENCES, 2019, 315
  • [49] Anti-cancer therapies targeting the tumor stroma
    Valeska Hofmeister
    David Schrama
    Jürgen C. Becker
    Cancer Immunology, Immunotherapy, 2008, 57 : 1 - 17
  • [50] Nuclear assembly as a target for anti-cancer therapies
    Gorjanacz, Matyas
    NUCLEUS, 2014, 5 (01) : 47 - 55